longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Eli Lilly

LLY

1,136.1100.19% ( -2.170 )
Closed: Sep 15, 15:59:42 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 40.12, below the reasonable range, cheaper than 91.02% of the time in the past 5 years, and the industry ranks 49/257, the industry Median -1.28.

40.12xP/E
$1,138.28Stock price
$28.38Earnings per share
40.12xP/E
Stock price$1,138.28Earnings per share$28.38

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
56.36x
Typical range
43.47x–103.42x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
LLYUSEli Lilly
40.12x53.26%$1.07T
RPRXUSRoyalty Pharma PLC - CL
41.82x77.88%$33.95B
LQDAUSLiquidia Tech
42.17x476.41%$5.85B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.